Volpara Health Technologies Ltd (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $291.26 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 254.83 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 3.17%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Volpara Health Technologies Ltd (ASX: VHT)
    Latest News

    A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.
    Small Cap Shares

    2 top small cap ASX shares that might be buys

    Adore Beauty and Volpara are two small cap ASX shares that could be worth looking at for growth potential.

    Read more »

    Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
    Small Cap Shares

    2 buy-rated small cap ASX shares tipped for strong growth

    These small cap shares could have bright futures ahead of them...

    Read more »

    Bag of white pills spilled onto a blue surface
    Healthcare Shares

    2 excellent ASX healthcare shares named as buys

    These healthcare shares have been tipped to shine...

    Read more »

    A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.
    Small Cap Shares

    2 small cap ASX shares that are growing quickly

    City Chic and Volpara are two small cap ASX shares that are growing rapidly.

    Read more »

    two hands wearing medical gloves make the shape of a heart, indicating the best healthcare shares on the ASX market
    Growth Shares

    3 reasons why the Volpara (ASX:VHT) share price could be a buy

    Volpara is a quality business and it could be worth looking into.

    Read more »

    ASX share price on watch represented by man looking through magnifying glass
    Small Cap Shares

    3 exciting small cap ASX shares to watch

    Alcidion Group Ltd (ASX:ALC) and these exciting small cap ASX shares could be worthy of a spot on your watchlist...

    Read more »

    A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy' indicating its the bottom of the falling market and time to buy ASX shares
    Technology Shares

    2 ASX shares that could be buys in June 2021

    June 2021 could be a good month to focus on quality ASX shares that growth plans and good potential for…

    Read more »

    Graphic showing yellow arrow above vertical columns indicating a rising share price
    Growth Shares

    2 great ASX growth shares that might be buys

    These two ASX growth shares could be good buys at the current prices, including Volpara Health Technologies Ltd (ASX:VHT).

    Read more »

    A doctor looks unsure, indicating share price uncertainty for ASX medical companies
    Share Market News

    Volpara (ASX:VHT) share price pushes higher on FY 2021 results

    The Volpara Health Technologies Ltd (ASX:VHT) share price is on the move on Thursday following the release of its full…

    Read more »

    Graphic showing yellow arrow above vertical columns indicating a rising share price
    Small Cap Shares

    3 growing small cap ASX shares to watch

    Serko Ltd (ASX:SKO) and these growing small cap ASX shares could be worth watching closely in the 2020s...

    Read more »

    a surprised investor reading about an asx share price in a newspaper
    Small Cap Shares

    3 exciting small cap ASX shares to watch

    Whispir Ltd (ASX:WSP) and these exciting small cap ASX shares could have bright futures ahead of them. Here's why...

    Read more »

    Small Cap Shares

    2 growing small cap ASX shares you need to know

    Here's why you need to know about Bigtincan Holdings Ltd (ASX:BTH) and this small cap ASX share...

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies Ltd

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    VHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    29 Apr 2024 $1.14 $0.00 0.00% 59,122 $1.14 $1.15 $1.14
    26 Apr 2024 $1.14 $0.00 0.00% 1,436,577 $1.14 $1.15 $1.14
    24 Apr 2024 $1.14 $0.00 0.00% 1,385,421 $1.14 $1.15 $1.14
    23 Apr 2024 $1.14 $0.00 0.00% 70,916 $1.14 $1.15 $1.14
    22 Apr 2024 $1.14 $0.00 0.00% 71,273 $1.14 $1.15 $1.14
    19 Apr 2024 $1.14 $0.00 0.00% 935,592 $1.14 $1.14 $1.14
    18 Apr 2024 $1.14 $0.00 0.00% 1,057,317 $1.15 $1.15 $1.14
    17 Apr 2024 $1.14 $0.00 0.00% 400,464 $1.14 $1.14 $1.14
    16 Apr 2024 $1.14 $0.00 0.00% 188,376 $1.14 $1.14 $1.14
    15 Apr 2024 $1.14 $0.00 0.00% 176,419 $1.14 $1.14 $1.14
    12 Apr 2024 $1.14 $0.00 0.00% 689,013 $1.14 $1.14 $1.14
    11 Apr 2024 $1.14 $0.00 0.00% 299,719 $1.14 $1.14 $1.14
    10 Apr 2024 $1.14 $0.00 0.00% 167,783 $1.14 $1.14 $1.14
    09 Apr 2024 $1.14 $0.00 0.00% 719,436 $1.14 $1.14 $1.14
    08 Apr 2024 $1.14 $0.00 0.00% 333,112 $1.14 $1.14 $1.13
    05 Apr 2024 $1.14 $0.01 0.88% 510,800 $1.14 $1.14 $1.14
    04 Apr 2024 $1.13 $-0.01 -0.88% 44,939 $1.14 $1.14 $1.13
    03 Apr 2024 $1.14 $0.01 0.88% 143,349 $1.13 $1.14 $1.13

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Aug 2023 Mark Bouw Issued 450,000 $585,000
    Issue of options.
    02 Jun 2023 Teri Thomas Sell 3,577 $2,546
    On-market trade.
    01 Jun 2023 Teri Thomas Buy 75,280 $57,213
    Conversion of securities. As per announcement on 02-06-2023
    01 Jun 2023 Teri Thomas Exercise 75,280 $57,213
    Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Roger Allen Non-Executive Director Jun 2010
    Roger was Volpara s first major investor, joined the Board
    prior to FDA approval in June 2010, and was Chair from
    October 2015 to March 2019.
    Roger is a well-known entrepreneur, venture capitalist (VC),
    and social impact investor and philanthropist whose global
    career has spanned over 50 years. He helped pioneer the
    Australian technology industry through the Computer
    Power Group, one of the first Australian-founded tech
    companies to scale globally and subsequently IPO in 1987,
    turning over approx. $1B in today s currency. Following
    the companys acquisition in 1995, he cofounded Allen &
    Buckeridge Pty Ltd, one of the first early-stage VC firms.
    Mr John Dimitrious Pavlidis Non-Executive Director Feb 2015
    John Pavlidis joined the VHT board in February
    2015 and has more than 30 years of experience
    as a senior healthcare executive, CEO, or
    company director in the areas of womens health,
    diagnostic imaging, image analysis and artificial
    intelligence, and cardiovascular therapies.
    Mr Paul Reid Non-Executive DirectorNon-Executive Chairman Mar 2018
    Paul joined the Board in March 2018 and brings extensive
    commercial experience gained across a range of
    technology/Software as a Service businesses.
    He was the founding CEO and Chairman of Figured
    Limited, a fintech SaaS company that provides
    management accounting software to farmers in the
    United States, the United Kingdom ,
    Australia, and New Zealand . Figured was the
    NZ Hi-Tech Startup Company of the Year in 2016 and
    has grown at an incredible pace, funded by private,
    corporate and venture capital (VC) investors.
    Ms Karin Lindgren Non-Executive Director Jan 2020
    Karin joined the Board in 2020. She brings over 35 years
    experience in health information technology as a senior
    technology executive and law firm partner. As one of
    the earliest healthcare technology lawyers in the USA,
    Karin has an in-depth knowledge of data governance,
    data privacy, SaaS, and US healthcare, and has extensive
    professional networks across the IT landscape
    Ms Ann Custin Non-Executive Director Sep 2021
    network of industry contacts from an extensive
    career in healthcare across Europe, the Americas,
    and Asia. Her most recent executive role was with
    Siemens Healthineers, where she served as both CFO
    and board director of Siemens Medical Solutions.
    Prior to this role, Ann served as Chief Operating
    and Financial Officer of Scientx and President &
    CEO of USA Draeger Medical Systems, Inc.
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Mark Bouw Non-Executive Director Jan 2023
    Mr Bouw is a experienced senior healthcare CEO .He is a visiting consultant at Stanford University Graduate Business School Seed Program in the United States and is a visiting mentor for Stanfords Ignite program.
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note